FNS-007

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameFNS-007
Drug Alias NameFNS-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHLA-DR antigens blockersHuman leukocyte antigen modulators
TargetsHLA-DR antigensHuman leukocyte antigen
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHebei Phoenix Biotechnology Co LtdCSPC Pharmaceutical Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHebei Phoenix Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A